← Leaderboards
Joanna L Jankowsky
California Institute Of Technology
$20,075,224
Attributed
$22,478,868
Total exposure
19
Grants
18
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.5M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$22,478,868 · 19
By mechanism
R01$7,963,900 · 4
RF1$7,634,934 · 3
P01$2,572,410 · 2
DP2$2,434,636 · 1
R21$1,205,068 · 3
K01$622,350 · 1
Top collaborators
- Ismael Al-Ramahi3 shared
- Olivier Lichtarge3 shared
Most similar at California Institute Of Technology
Same institution · by research overlap
- Henry A. Lester$27,901,447
- Dennis A Dougherty$8,653,143
- Douglas C Rees$15,193,660
- Rob Phillips$20,563,238
- Elizabeth S Haswell$588,927
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposS DiseaseBrainNeuronsMouse ModelIn VivoAdultAnimalsAffectCellsPathogenesisImpaired CognitionProteinsLinkVariantMemoryMorphologyResponseLearningIn VitroTransgenic MiceInsightCognitive FunctionOverexpression
Grant awards (42)
Gene therapy for Alzheimer's disease using virally delivered Abeta variants$560,962
R01 · FY2025 · AG · contact PI
Causes and consequences of differential APP processing in inhibitory and excitatory neurons$544,855
R01 · FY2025 · AG · contact PI
TMEM106b as a lysosomal adaptor to influence brain aging and tau pathogenesis$476,740
P01 · FY2025 · AG · contact PI
Causes and consequences of differential APP processing in inhibitory and excitatory neurons$51,473
R01 · FY2025 · AG · contact PI
Causes and consequences of differential APP processing in inhibitory and excitatory neurons$713,402
R01 · FY2024 · AG · contact PI
Gene therapy for Alzheimer's disease using virally delivered Aβ variants$588,974
R01 · FY2024 · AG · contact PI
TMEM106b as a lysosomal adaptor to influence brain aging and tau pathogenesis$526,204
P01 · FY2024 · AG · contact PI
Decoding the impact of sex differences on Alzheimer's disease risk$1,201,822
R01 · FY2023 · AG
TMEM106b as a lysosomal adaptor to influence brain aging and tau pathogenesis$526,207
P01 · FY2023 · AG · contact PI
Decoding the impact of sex differences on Alzheimer's disease risk$1,201,822
R01 · FY2022 · AG
TMEM106b as a lysosomal adaptor to influence brain aging and tau pathogenesis$517,052
P01 · FY2022 · AG · contact PI
Gene therapy for Alzheimer's disease using virally delivered Aβ variants$139,788
RF1 · FY2022 · AG · contact PI
Gene therapy for Alzheimer's disease using virally delivered Aβ variants$1,788,342
RF1 · FY2021 · AG · contact PI
Decoding the impact of sex differences on Alzheimer's disease risk$1,201,822
R01 · FY2021 · AG
TMEM106b as a lysosomal adaptor to influence brain aging and tau pathogenesis$526,207
P01 · FY2021 · AG · contact PI
Plasticity of the entorhinal-hippocampal circuit as a vulnerability in AD$214,132
RF1 · FY2020 · AG · contact PI
Plasticity of the entorhinal-hippocampal circuit as a vulnerability in Alzheimerâs Disease$158,658
RF1 · FY2019 · AG · contact PI
Deconstructing the pathogenic effect of APP in memory circuits$474,692
R01 · FY2018 · NS · contact PI
Modeling genetic modifiers of cognitive reserve in AD$237,750
R21 · FY2018 · AG · contact PI
Plasticity of the entorhinal-hippocampal circuit as a vulnerability in AD$2,795,215
RF1 · FY2017 · AG · contact PI
Deconstructing the pathogenic effect of APP in memory circuits$474,692
R01 · FY2017 · NS · contact PI
Modeling genetic modifiers of cognitive reserve in AD$198,125
R21 · FY2017 · AG · contact PI
Interrogating the link between aging and AD with temporally-controlled transgenes$2,538,799
RF1 · FY2016 · AG · contact PI
Deconstructing the pathogenic effect of APP in memory circuits$474,692
R01 · FY2016 · NS · contact PI
Deconstructing the pathogenic effect of APP in memory circuits$474,692
R01 · FY2015 · NS · contact PI
Selective neuronal silencing to study hippocampal neurogenesis in depression$234,750
R21 · FY2014 · MH · contact PI
Selective neuronal silencing to study hippocampal neurogenesis in depression$195,625
R21 · FY2013 · MH · contact PI
Distinguishing cell-intrinsic and cell-extrinsic effects of APP/Abeta in vivo$181,480
R21 · FY2011 · AG · contact PI
HIGH-RESOLUTION EX VIVO IMAGING OF AN ALZHEIMER'S MOUSE MODEL$12,272
P41 · FY2011 · RR · contact PI
Distinguishing cell-intrinsic and cell-extrinsic effects of APP/Abeta in vivo$157,338
R21 · FY2010 · AG · contact PI
Selective neuronal silencing to study cognitive decline in Alzheimer's disease$120,486
DP2 · FY2010 · OD · contact PI
HIGH-RESOLUTION EX VIVO IMAGING OF AN ALZHEIMER'S MOUSE MODEL$10,920
P41 · FY2010 · RR · contact PI
HIGH-RESOLUTION EX VIVO IMAGING OF AN ALZHEIMER'S MOUSE MODEL$10,920
P41 · FY2009 · RR · contact PI
Interaction of ABeta & the alpha7 AChR in mouse AD model$124,470
K01 · FY2008 · AG · contact PI
HIGH-RESOLUTION EX VIVO IMAGING OF AN ALZHEIMER'S MOUSE MODEL$6,473
P41 · FY2008 · RR · contact PI
Selective neuronal silencing to study cognitive decline in Alzheimer's disease$2,092,130
DP2 · FY2007 · OD · contact PI
Selective neuronal silencing to study cognitive decline in Alzheimer's disease$222,020
DP2 · FY2007 · OD · contact PI
Interaction of ABeta & the alpha7 AChR in mouse AD model$124,470
K01 · FY2007 · AG · contact PI
HIGH-RESOLUTION EX VIVO IMAGING OF AN ALZHEIMER'S MOUSE MODEL$4,985
P41 · FY2007 · RR · contact PI
Interaction of ABeta & the alpha7 AChR in mouse AD model$124,470
K01 · FY2006 · AG · contact PI
Interaction of ABeta &the alpha7 AChR in mouse AD model$124,470
K01 · FY2005 · AG
Interaction of ABeta &the alpha7 AChR in mouse AD model$124,470
K01 · FY2004 · AG